Cargando…
Structure and activation of the TSH receptor transmembrane domain
PURPOSE: The thyroid-stimulating hormone receptor (TSHR) is the target autoantigen for TSHR-stimulating autoantibodies in Graves’ disease. The TSHR is composed of: a leucine-rich repeat domain (LRD), a hinge region or cleavage domain (CD) and a transmembrane domain (TMD). The binding arrangements be...
Autores principales: | Núñez Miguel, Ricardo, Sanders, Jane, Furmaniak, Jadwiga, Smith, Bernard Rees |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136658/ https://www.ncbi.nlm.nih.gov/pubmed/27921237 http://dx.doi.org/10.1007/s13317-016-0090-1 |
Ejemplares similares
-
Blocking type TSH receptor antibodies
por: Furmaniak, Jadwiga, et al.
Publicado: (2012) -
TSH receptor specific monoclonal autoantibody K1‐70(TM) targeting of the TSH receptor in subjects with Graves' disease and Graves' orbitopathy—Results from a phase I clinical trial
por: Furmaniak, Jadwiga, et al.
Publicado: (2022) -
Structure of full-length TSH receptor in complex with antibody K1-70™
por: Núñez Miguel, Ricardo, et al.
Publicado: (2022) -
Preclinical studies on the toxicology, pharmacokinetics and safety of K1-70(TM) a human monoclonal autoantibody to the TSH receptor with TSH antagonist activity
por: Furmaniak, Jadwiga, et al.
Publicado: (2019) -
Practical applications of studies on the TSH receptor and TSH receptor autoantibodies
por: Furmaniak, J., et al.
Publicado: (2020)